RETROPERITONEAL NEOPLASM METASTATIC

This adverse event was reported 33 times

These drugs are most commonly taken by patients reporting RETROPERITONEAL NEOPLASM METASTATIC:

# Drug Count
0 CAPECITABINE 13
1 PACLITAXEL 9
2 GEMCITABINE 7
3 GEMCITABINE HYDROCHLORIDE 7
4 CISPLATIN 6
5 OXALIPLATIN 5
6 PEMIGATINIB 5
7 FLUOROURACIL 4
8 FLUOROURACIL CREAM, 0.5% 4
9 FOLIC ACID 4
See all common drugs associated with RETROPERITONEAL NEOPLASM METASTATIC

RETROPERITONEAL NEOPLASM METASTATIC is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 PEMIGATINIB 5 0.0059
1 FUTIBATINIB 1 0.0045
2 EPOETIN ALFA-EPBX 1 0.0004
3 TAMOXIFEN CITRATE 2 0.0003
4 SIPULEUCEL-T 2 0.0003
5 CABAZITAXEL 1 0.0003
6 GLUCAGON 1 0.0002
7 BISMUTH SUBSALICYLATE 1 0.0002
8 LUTETIUM LU 177 DOTATATE 1 0.0002
9 IRINOTECAN HYDROCHLORIDE 2 0.0002
See all drugs enriched for association with RETROPERITONEAL NEOPLASM METASTATIC